- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-8798
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Review of preventative HIV vaccine clinical trials in South Africa ; day:14 ; month:8 ; year:2020 ; pages:1-14
Archives of virology ; (14.8.2020), 1-14
- Urheber
-
Laher, Fatima
Bekker, Linda-Gail
Garrett, Nigel
Lazarus, Erica M.
Gray, Glenda E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00705-020-04777-2
- URN
-
urn:nbn:de:101:1-2020100719144175466964
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 00:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Laher, Fatima
- Bekker, Linda-Gail
- Garrett, Nigel
- Lazarus, Erica M.
- Gray, Glenda E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
Gender Mainstreaming in HIV Vaccine Trials in India
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
Barriers to participation in HIV vaccine trials and cancer trials: a cost-gain analysis
Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities
Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
Willingness to Participate in HIV Vaccine Trials Among Young Nale Nigerian Traders
Statistics in clinical vaccine trials
Motivators to participation in HIV vaccine trials and cancer trials: the application of personal and social categorization
Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
Gender Mainstreaming in HIV Vaccine Trials in India
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
Barriers to participation in HIV vaccine trials and cancer trials: a cost-gain analysis
Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities
Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
Willingness to Participate in HIV Vaccine Trials Among Young Nale Nigerian Traders
Statistics in clinical vaccine trials
Motivators to participation in HIV vaccine trials and cancer trials: the application of personal and social categorization
Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa
P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
Gender Mainstreaming in HIV Vaccine Trials in India
P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa
Barriers to participation in HIV vaccine trials and cancer trials: a cost-gain analysis
Designing HIV Vaccine Efficacy Trials in the Context of Highly Effective Non-vaccine Prevention Modalities
Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
Willingness to Participate in HIV Vaccine Trials Among Young Nale Nigerian Traders
Statistics in clinical vaccine trials